Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
23 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
65.4 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
57
57 articles ont été cités au moins 57fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
13 986
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
338
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
127
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Association between obstructive sleep apnea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease
2026ArticleSleep
Pre-liver transplant assessment of patients with acute-on-chronic liver failure: an international survey
2026ArticleJHEP Reports Innovation in Hepatology
Aortic valve calcium score from computed tomography for signal localization by cardiac amyloid radionuclide imaging to predict aortic stenosis and assess prognosis in patients with transthyretin cardiomyopathy
2026ArticleEuropean Journal of Nuclear Medicine and Molecular Imaging
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial
2025ArticleJournal of Hepatology
Association between obstructive sleep apnoea and liver fibrosis in patients with suspected nonalcoholic fatty liver disease
2025ArticleSleep
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
2025ArticleThe Lancet Gastroenterology & Hepatology
OS-032 Comparative perioperative morbidity and mortality of transplantation for alcohol-related hepatitis or liver disease: data from the QuickTrans study
2025CongrèsEASL Congress 2025
SAT-374-YI Health related quality of life in patients with porto-sinusoidal vascular disorder
2025ArticleJournal of Hepatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET DU DR CHRISTOPHE BUREAU
9 PLACE DE L EGLISE, 77120 SAINTS
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The lancet. Gastroenterology & hepatology · 2022
JAMA · 2023
ImportanceThe benefits of prophylactic antibiotics for hospitalized patients with severe alcohol-related hepatitis are unclear.ObjectiveTo determine the efficacy of amoxicillin-clavulanate, compared with placebo, on mortality in patients hospitalized with severe alcohol-related hepatitis and treated with prednisolone.Design, Setting, and ParticipantsMulticenter, randomized, double-blind clinical trial among patients with biopsy-proven severe alcohol-related hepatitis (Maddrey function score ≥32 and Model for End-stage Liver Disease [MELD] score ≥21) from June 13, 2015, to May 24, 2019, in 25 centers in France and Belgium. All patients were followed up for 180 days. Final follow-up occurred on November 19, 2019.InterventionPatients were randomly assigned (1:1 allocation) to receive prednisolone combined with amoxicillin-clavulanate (n = 145) or prednisolone combined with placebo (n = 147).Main Outcome and MeasuresThe primary outcome was all-cause mortality at 60 days. Secondary outcomes were all-cause mortality at 90 and 180 days; incidence of infection, incidence of hepatorenal syndrome, and proportion of participants with a MELD score less than 17 at 60 days; and proportion of patients with a Lille score less than 0.45 at 7 days.ResultsAmong 292 randomized patients (mean age, 52.8 [SD, 9.2] years; 80 [27.4%] women) 284 (97%) were analyzed. There was no significant difference in 60-day mortality between participants randomized to amoxicillin-clavulanate and those randomized to placebo (17.3% in the amoxicillin-clavulanate group and 21.3% in the placebo group [P = .33]; between-group difference, −4.7% [95% CI, −14.0% to 4.7%]; hazard ratio, 0.77 [95% CI, 0.45-1.31]). Infection rates at 60 days were significantly lower in the amoxicillin-clavulanate group (29.7% vs 41.5%; mean difference, −11.8% [95% CI, −23.0% to −0.7%]; subhazard ratio, 0.62; [95% CI, 0.41-0.91]; P = .02). There were no significant differences in any of the remaining 3 secondary outcomes. The most common serious adverse events were related to liver failure (25 in the amoxicillin-clavulanate group and 20 in the placebo group), infections (23 in the amoxicillin-clavulanate group and 46 in the placebo group), and gastrointestinal disorders (15 in the amoxicillin-clavulanate group and 21 in the placebo group).Conclusion and RelevanceIn patients hospitalized with severe alcohol-related hepatitis, amoxicillin-clavulanate combined with prednisolone did not improve 2-month survival compared with prednisolone alone. These results do not support prophylactic antibiotics to improve survival in patients hospitalized with severe alcohol-related hepatitis.Trial RegistrationClinicalTrials.gov Identifier: NCT02281929
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2026 · Letter
Tripon S, Benmassaoud A, Bureau C, Mallet M, et al.
La Revue du praticien · 2025 · Journal Article
Meszaros M, Bureau C
Hepatology (Baltimore, Md.) · 2024 · Journal Article
Maan R, Lauw MN, China L, Patch D, et al.
Liver international : official journal of the International Association for the Study of the Liver · 2023 · Observational Study
Villagrasa A, Hernández-Gea V, Bataller R, Giráldez Á, et al.
Clinics and research in hepatology and gastroenterology · 2023 · Journal Article
Ravaioli F, Berger A, Farcau O, Colecchia A, et al.
Clinics and research in hepatology and gastroenterology · 2022 · Journal Article
Calès P, Ravaioli F, Berger A, Farcau O, et al.
Liver international : official journal of the International Association for the Study of the Liver · 2022 · Journal Article
Louvet A, Trabut JB, Moreno C, Moirand R, et al.
The lancet. Gastroenterology & hepatology · 2022 · Controlled Clinical Trial
Louvet A, Labreuche J, Moreno C, Vanlemmens C, et al.
American journal of hematology · 2022 · Journal Article
Plessier A, Esposito-Farèse M, Baiges A, Shukla A, et al.
American heart journal · 2022 · Journal Article
Hara H, Serruys PW, O'Leary N, Gao C, et al.
International journal of cardiology · 2024 · Journal Article
Lointier E, Cariou E, Beneyto M, Fournier P, et al.
Hepatology (Baltimore, Md.) · 2024 · Journal Article
Sidali S, Borie R, Sicre de Fontbrune F, El Husseini K, et al.
Journal of hepatology · 2023 · Observational Study
Baiges A, Procopet B, Silva-Junior G, Llop E, et al.
Journal of hepatology · 2025 · Journal Article
Thévenot T, Elkrief L, Bureau C, Bardou-Jacquet E, et al.
The lancet. Gastroenterology & hepatology · 2025 · Journal Article
Cervoni JP, Weil D, Desmarets M, Lannes A, et al.
Journal of hepatology · 2026 · Journal Article
Bañares J, Pons M, Reiberger T, Mandorfer M, et al.
Journal of hepatology · 2024 · Letter
Larrue H, Bureau C, D'Amico G
Journal of hepatology · 2023 · Meta-Analysis
Larrue H, D'Amico G, Olivas P, Lv Y, et al.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie · 2024 · Journal Article
Laborde N, Barange K, Girard C, Marbach C, et al.
Journal of pediatric gastroenterology and nutrition · 2022 · Case Reports
Girard C, Laborde N, Marbach C, Mas E, et al.
Neurosurgery · 2024 · Journal Article
Sun X, Wu X, Yang M, Deng Y, et al.
Sleep · 2026 · Journal Article
Trzepizur W, Boursier J, Poilane J, Bureau C, et al.
JAMA · 2023 · Journal Article
Louvet A, Labreuche J, Dao T, Thévenot T, et al.